References
1. Younis NK, Rahm M, Bitar F, Arabi M. COVID-19 in the MENA Region:
Facts and Findings. The Journal of Infection in Developing
Countries . 2021;15(03):342-349.
2. Kelly-Cirino CD, Nkengasong J, Kettler H, et al. Importance of
diagnostics in epidemic and pandemic preparedness. BMJ global
health . 2019;4(Suppl 2):e001179.
3. Alarcón Garavito GA, Moniz T, Déom N, Redin F, Pichini A,
Vindrola-Padros C. The implementation of large-scale genomic screening
or diagnostic programmes: a rapid evidence review. European
Journal of Human Genetics . 2023;31(3):282-295.
4. Fawcett L. The Middle East and COVID-19: time for collective action.Globalization and Health . 2021;17(1):133.
5. Al-Hosani F, Al-Mazrouei S, Al-Memari S, Al-Yafei Z, Paulo MS,
Koornneef E. A Review of COVID-19 Mass Testing in the United Arab
Emirates. Front Public Health . 2021;9:661134.
doi:10.3389/fpubh.2021.661134
6. Alsafar H, Albreiki M, Mousa M, et al. Genomic epidemiology and
emergence of SARS-CoV-2 variants of concern in the United Arab Emirates.Scientific Reports . 2022;12(1):14669.
7. Abuyadek R, Amirtharaj F, Al Marzooqi S, Mahmoud S, Al Hosani F.
Combined epidemiology and genetic sequencing surveillance in the era of
COVID-19 pandemic; Abu Dhabi experience, United Arab Emirates.Infection, Genetics and Evolution . 2023;109:105411.
8. Pembaur A, Sallard E, Weil PP, Ortelt J, Ahmad-Nejad P, Postberg J.
Simplified point-of-care full SARS-CoV-2 genome sequencing using
nanopore technology. Microorganisms . 2021;9(12):2598.
9. Freed NE, Vlková M, Faisal MB, Silander OK. Rapid and inexpensive
whole-genome sequencing of SARS-CoV-2 using 1200 bp tiled amplicons and
Oxford Nanopore Rapid Barcoding. Biology Methods and Protocols .
2020;5(1):bpaa014.
10. Bown CP. How COVID‐19 Medical Supply Shortages Led to
Extraordinary Trade and Industrial Policy . Asian Economic Policy
Review. 2022 Jan;17(1):114-35. doi: 10.1111/aepr.12359. Epub 2021 Jul
29.
11. Parkes P, Pillay TD, Bdaiwi Y, et al. Telemedicine interventions in
six conflict-affected countries in the WHO Eastern Mediterranean region:
a systematic review. Conflict and Health . 2022;16(1):64.
12. Khoury P, Azar E, Hitti E. COVID-19 Response in Lebanon: Current
Experience and Challenges in a Low-Resource Setting. JAMA .
2020;324(6):548-549. doi:10.1001/jama.2020.12695
13. Akkad BA, Mouselli S. Syrian SMEs in Times of COVID-19 Pandemic:
Challenges, Adaptation, and Policy Measures. Journal of Risk and
Financial Management . 2023;16(3):142.
14. Alhaffar M, Janos S. Public health consequences after ten years of
the Syrian crisis: a literature review. Global Health . Sep 19
2021;17(1):111. doi:10.1186/s12992-021-00762-9
15. El Sayed MJ. Beirut Ammonium Nitrate Explosion: A Man-Made Disaster
in Times of the COVID-19 Pandemic. Disaster Med Public Health
Prep . Jun 2022;16(3):1203-1207. doi:10.1017/dmp.2020.451
16. El Zahran T, Geha M, Sakr F, Bachir R, El Sayed M. The Beirut Port
Blast: spectrum of injuries and clinical outcomes at a large tertiary
care center in Beirut, Lebanon. Eur J Trauma Emerg Surg . Dec
2022;48(6):4919-4926. doi:10.1007/s00068-022-02023-9
17. Swed S, Alibrahim H, Sawaf B, Alzabibi MA, Shibani M, Sakkour R.
COVID-19, war and poverty in Syria. Ann Med Surg (Lond) . Mar
2022;75:103382. doi:10.1016/j.amsu.2022.103382
18. Dhabaan GN, Al-Soneidar WA, Al-Hebshi NN. Challenges to testing
COVID-19 in conflict zones: Yemen as an example. J Glob Health .
Jun 2020;10(1):010375. doi:10.7189/jogh.10.010375
19. consortium TCGU. An integrated national scale SARS-CoV-2 genomic
surveillance network. The Lancet Microbe . 2020;1(3):e99-e100.
doi:10.1016/S2666-5247(20)30054-9
20. Sperber NR, Carpenter JS, Cavallari LH, et al. Challenges and
strategies for implementing genomic services in diverse settings:
experiences from the Implementing GeNomics In pracTicE (IGNITE) network.BMC Medical Genomics . 2017/05/22 2017;10(1):35.
doi:10.1186/s12920-017-0273-2
21. Fiolet T, Kherabi Y, MacDonald C-J, Ghosn J, Peiffer-Smadja N.
Comparing COVID-19 vaccines for their characteristics, efficacy and
effectiveness against SARS-CoV-2 and variants of concern: a narrative
review. Clinical Microbiology and Infection . 2022;28(2):202-221.
22. Bergmans BJ, Reusken CB, Van Oudheusden AJ, et al. Test, trace,
isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical
cohort. Diagnostic Microbiology and Infectious Disease .
2021;101(2):115392.
23. Isabel S, Abdulnoor M, Boissinot K, et al. Emergence of a mutation
in the nucleocapsid gene of SARS-CoV-2 interferes with PCR detection in
Canada. Scientific Reports . 2022;12(1):10867.
24. Vitiello A, Ferrara F, Auti AM, Di Domenico M, Boccellino M.
Advances in the Omicron variant development. Journal of internal
medicine . 2022;292(1):81-90.
25. Chaguza C, Coppi A, Earnest R, et al. Rapid emergence of SARS-CoV-2
Omicron variant is associated with an infection advantage over Delta in
vaccinated persons. Med . 2022;3(5):325-334. e4.
26. Nadon C, Croxen M, Knox N, et al. Public health genomics capacity
assessment: readiness for large-scale pathogen genomic surveillance in
Canada’s public health laboratories. BMC Public Health .
2022/09/24 2022;22(1):1817. doi:10.1186/s12889-022-14210-9
27. Moyo E, Moyo P, Mashe T, Dzobo M, Chitungo I, Dzinamarira T.
Implementation of Public Health Genomics in Africa: Lessons from the
COVID-19 pandemic, challenges, and recommendations. J Med Virol .
Jan 2023;95(1):e28295. doi:10.1002/jmv.28295
28. Ling-Hu T, Rios-Guzman E, Lorenzo-Redondo R, Ozer EA, Hultquist JF.
Challenges and Opportunities for Global Genomic Surveillance Strategies
in the COVID-19 Era. Viruses . Nov 16
2022;14(11)doi:10.3390/v14112532
29. Saad RK, Al Nsour M, Khader Y, Al Gunaid M. Public Health
Surveillance Systems in the Eastern Mediterranean Region: Bibliometric
Analysis of Scientific Literature. JMIR Public Health Surveill .
Nov 1 2021;7(11):e32639. doi:10.2196/32639
30. Bruinenberg M, Frey M, Napier M, Summers A. Comparing the
hub-and-spoke model practices of the LifeLines Study in the Netherlands
and the H3Africa Initiative. Biopreserv Biobank . Feb
2014;12(1):13-6. doi:10.1089/bio.2013.0057
31. Kasivisvanathan R, Tilney HS, Jhanji S, et al. The ‘hub and spoke
model’ for the management of surgical patients during the COVID-19
pandemic. The International Journal of Health Planning and
Management . 2021;36(5):1397-1406.
doi:https://doi.org/10.1002/hpm.3243
32. Xu X, Rodgers MD, Guo WG. A hub-and-spoke design for ultra-cold
COVID-19 vaccine distribution. Vaccine . Oct 1
2021;39(41):6127-6136. doi:10.1016/j.vaccine.2021.08.069
33. Srivastava S, Datta V, Garde R, et al. Development of a hub and
spoke model for quality improvement in rural and urban healthcare
settings in India: a pilot study. BMJ Open Qual . Aug
2020;9(3)doi:10.1136/bmjoq-2019-000908
34. Genomic Laboratory Hubs. NHS England. Accessed 22 May 2023, 2023.
https://www.england.nhs.uk/genomics/genomic-laboratory-hubs/